Dyne Therapeutics DYN
NASDAQ DYN
$17.99 +0.07 (+0.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Dyne Therapeutics (DYN) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Dyne Therapeutics (DYN) posted Return on Capital Employed [ROCE] of -55.99% for Q2 2026, up 8.50 percentage points from -64.49% a year earlier but down 12.46 percentage points from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Dyne Therapeutics' Return on Capital Employed [ROCE] came in at -52.70%, up 36.42 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -18.97 percentage points (FY2020 to FY2025).
  • In prior years, Dyne Therapeutics' Return on Capital Employed [ROCE] was -89.11% in FY2024 (+42.06 pp), -131.18% in FY2023 (-80.58 pp), -50.59% in FY2022 (-9.01 pp) and -41.58% in FY2021 (-7.86 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -180.63% in Q4 2023 to a high of -28.55% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last three quarters, with an average year-over-year change of +25.64 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2024, with a gain of 130.64 percentage points; the weakest was Q4 2023, with a drop of 118.44 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -43.53% (Q1 2026), -47.95% (Q4 2025) and -60.85% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Dyne Therapeutics 3.36 Bn -757.60 Mn - -60.57%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -60.57%
Jun 30, 2026 -55.99%
Mar 31, 2026 -43.53%
Dec 31, 2025 -47.95%
Sep 30, 2025 -60.85%
Jun 30, 2025 -64.49%
Mar 31, 2025 -59.06%
Dec 31, 2024 -49.99%
Sep 30, 2024 -41.69%
Jun 30, 2024 -42.07%
Mar 31, 2024 -82.74%
Dec 31, 2023 -180.63%
Sep 30, 2023 -108.04%
Jun 30, 2023 -77.91%
Mar 31, 2023 -65.47%
Dec 31, 2022 -62.19%
Sep 30, 2022 -61.64%
Jun 30, 2022 -54.18%
Mar 31, 2022 -41.90%
Dec 31, 2021 -35.93%
API Access

Dyne Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DYN&period=max&api_key=YOUR_API_KEY